Literature DB >> 19345263

Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III.

Robert Jan Lebbink1, Nicolas Raynal, Talitha de Ruiter, Dominique G Bihan, Richard W Farndale, Linde Meyaard.   

Abstract

Immune responses are tightly controlled by the opposing actions of activating and inhibitory immune receptors. Previously we identified collagens as ligands for the inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1), revealing a novel mechanism of peripheral immune regulation by inhibitory immune receptors binding to extracellular matrix collagens. This interaction can be blocked by LAIR-2, a secreted member of the LAIR-1 family. LAIR-1 specifically interacts with synthetic trimeric peptides containing 10 repeats of glycine-proline-hydroxyproline (GPO) residues which can directly inhibit immune cell activation in vitro. Here we studied the interaction of human LAIR-1 and LAIR-2 with collagen in more detail by using novel overlapping synthetic trimeric peptides (Toolkits) encompassing the entire triple-helical domain of human collagens II and III. LAIR-1 and LAIR-2 bind several of these collagen-like peptides, with LAIR-2 being able to bind more than LAIR-1. LAIR binding to trimeric collagen peptides was influenced by GPO content of the peptide, although additional non-GPO triplets contributed to the interaction. Furthermore, we identified several trimeric peptides that were potent LAIR-1 ligands and could efficiently induce inhibition of T cell activation and FceRI-induced degranulation of RBL-2H3 cells through binding to LAIR-1. A detailed understanding of the LAIR recognition motifs within collagen may lead to the development of potent reagents that can be used in in vitro, ex vivo, and in vivo functional studies to dissect the biology and function of the collagen/LAIR-1 interaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345263     DOI: 10.1016/j.matbio.2009.03.005

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  41 in total

Review 1.  The collagen family.

Authors:  Sylvie Ricard-Blum
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

Review 2.  Extracellular Matrix-Based Strategies for Immunomodulatory Biomaterials Engineering.

Authors:  Andrew T Rowley; Raji R Nagalla; Szu-Wen Wang; Wendy F Liu
Journal:  Adv Healthc Mater       Date:  2019-02-04       Impact factor: 9.933

3.  The NC2 domain of type IX collagen determines the chain register of the triple helix.

Authors:  Sergei P Boudko; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

4.  First analysis of a bacterial collagen-binding protein with collagen Toolkits: promiscuous binding of YadA to collagens may explain how YadA interferes with host processes.

Authors:  Jack C Leo; Heli Elovaara; Dominique Bihan; Nicholas Pugh; Sami K Kilpinen; Nicolas Raynal; Mikael Skurnik; Richard W Farndale; Adrian Goldman
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

5.  Osteogenesis imperfecta missense mutations in collagen: structural consequences of a glycine to alanine replacement at a highly charged site.

Authors:  Jianxi Xiao; Haiming Cheng; Teresita Silva; Jean Baum; Barbara Brodsky
Journal:  Biochemistry       Date:  2011-11-22       Impact factor: 3.162

Review 6.  Crafting of functional biomaterials by directed molecular self-assembly of triple helical peptide building blocks.

Authors:  Jayati Banerjee; Helena S Azevedo
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

7.  Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway.

Authors:  Jeoung-Eun Park; David D Brand; Edward F Rosloniec; Ae-Kyung Yi; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  J Biol Chem       Date:  2020-01-13       Impact factor: 5.157

Review 8.  Synthesis and biological applications of collagen-model triple-helical peptides.

Authors:  Gregg B Fields
Journal:  Org Biomol Chem       Date:  2010-01-20       Impact factor: 3.876

Review 9.  Tailoring Natural Killer cell immunotherapy to the tumour microenvironment.

Authors:  Alexander David Barrow; Marco Colonna
Journal:  Semin Immunol       Date:  2017-09-19       Impact factor: 11.130

10.  The Role of Leukocyte-Associated Ig-like Receptor-1 in Suppressing Collagen-Induced Arthritis.

Authors:  Seunghyun Kim; Ellis R Easterling; Lauren C Price; Savannah L Smith; John E Coligan; Jeoung-Eun Park; David D Brand; Edward F Rosloniec; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  J Immunol       Date:  2017-09-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.